After acquiring LumenR and EndoChoice, Boston Scientific committed to leaning on its endoscopy business to drive growth company-wide, Trefis reports. Here’s what you need to know. 1. In addition to ...
BSX's Endoscopy unit targets an $8B market, spanning pancreaticobiliary, surgery and obesity, with plans to outgrow the market.
Recently, Boston Scientific won U.S. Food and Drug Administration (:FDA) and CE mark approval for the Expect Slimline (SL.V) Needle. The product, which has been launched globally, will be used for ...
Boston Scientific is investing $19 million in a new Galway, Ireland-based RoadRunner endoscopy design facility, Galway Advertiser reports. 1. The company said by 2020 it’ll also invest $19 million in ...
Zacks Investment Research on MSN
If you invested $1000 in Boston Scientific 10 years ago, this is how much you'd have now
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and ...
Boston Scientific Corporation BSX recently announced the receipt of CE Mark for its EXALT Model B Single-Use Bronchoscope. Following the regulatory go-ahead, commercialization of the single-use ...
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...
DUBLIN, Aug. 18, 2021 /PRNewswire/ -- The "The US Endoscopy Device Market: Size & Forecast with Impact Analysis of COVID-19, 2021-2025" report has been added to ResearchAndMarkets.com's offering. The ...
Boston Scientific will expand its portfolio of products treating gastrointestinal conditions by purchasing EndoChoice Holdings Inc. for $210 million, the company said Tuesday. Boston Scientific—which ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback